REG - Danakali Limited - Appendix 3Y - S Cornelius

DanakaliAnnouncement

14/06/2019 09:30

RNS Number : 2978C
Danakali Limited
14 June 2019
 


Rule 3.19A.2
Appendix 3Y
 
Change of Director's Interest Notice
 
Information or documents not available now must be given to ASX as soon as available.  Information and documents given to ASX become ASX's property and may be made public.
Introduced 30/09/01  Amended 01/01/11
 



Name of entity      DANAKALI LTD




ABN                      56 097 904 302



 
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. 
 



Name of Director


Seamus Ian Cornelius




Date of last notice


9 November 2018



 
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
 
Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.
 



Direct or indirect interest


(a)    Direct
(b)   Indirect
(c)    Indirect
(d)   Indirect
 




Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant interest.
 


(b)   Kongming Investments Ltd - Director of the Company
(c)    Sino West Assets Ltd - Director of the Company
(d)   Seamus Ignatius Quan Cornelius - Son of Seamus Ian Cornelius
 




Date of change


14 June 2019
 




No. of securities held prior to change


Direct Holding
(a)   4,831,664 fully paid ordinary shares
 
(a)   300,000 unlisted (remuneration) options at $0.94, expiring on 19/05/2020
 
Indirect Holding
(b)   4,178,992 fully paid ordinary shares
 
  (c)   1,318,309 fully paid ordinary shares
 
  (d)   Nil
 




Class


Unlisted Options at $1.031, expiring on 24/01/2022
 




Number acquired


301,040
 




Number disposed


Nil




Value/Consideration
Note: If consideration is non-cash, provide details and estimated valuation


$37,103 (non-cash) (black & scholes valuation)
 
 




No. of securities held after change


Direct Holding
(a)   4,831,664 fully paid ordinary shares
 
(a)   300,000 unlisted options (remuneration) at $0.94, expiring on 19/05/2020
 
Indirect Holding
(b)   4,178,992 fully paid ordinary shares
 
  (c)   1,318,309 fully paid ordinary shares
 
  (d)   301,040 unlisted options (remuneration) at $1.031, expiring on 24/01/2022
 




Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back


Unlisted Options issued as approved by shareholders at the Company's annual general meeting held 27 May 2019.



 
 
Part 2 - Change of director's interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.



Detail of contract


N/A




Nature of interest


N/A




Name of registered holder
(if issued securities)


N/A




Date of change


N/A




No. and class of securities to which interest related prior to change
Note: Details are only required for a contract in relation to which the interest has changed
 


N/A




Interest acquired


N/A




Interest disposed


N/A




Value/Consideration
Note: If consideration is non-cash, provide details and an estimated valuation
 


N/A




Interest after change


N/A



 
Part 3 - +Closed period



Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?


No




If so, was prior written clearance provided to allow the trade to proceed during this period?


N/A




If prior written clearance was provided, on what date was this provided?


N/A



 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUSVNRKOANARR